Physician profile
Anthony B Mcdowell
NPI 1437211422
$876.25
in general payments reported to CMS, 2019-2025
22 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $83.29 · 2021: $92.97 · 2022: $33.50 · 2023: $294 · 2024: $113 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.06 |
| Education | $197.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $168.55 | 2019-2025 | Veozah |
| Eisai INC. | $112.50 | 2023 | |
| Exeltis, USA INC. | $86.45 | 2019-2021 | |
| Hologic Sales and Service, LLC | $68.73 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $49.70 | 2021-2024 | Gardasil 9, Gardasil |
| Sage Therapeutics, LLC | $43.85 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $37.21 | 2020-2023 | |
| Boston Scientific Corporation | $35.94 | 2025 | General - Vascular Intervention |
| Roche Diagnostics Corporation | $33.61 | 2019-2020 | |
| Smith+Nephew, INC. | $28.53 | 2024 | Pico 7 |
| Mayne Pharma Commercial LLC | $24.35 | 2023 | |
| Acessa Health INC. | $23.58 | 2019 | |
| Evofem Biosciences, INC. | $21.92 | 2021 | |
| Intuitive Surgical, INC. | $18.42 | 2023 | Da Vinci Surgical System |
| Novo Nordisk INC | $18.29 | 2025 | Wegovy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $16.93 | 2023 | Twirla |
| Exact Sciences Corporation | $16.50 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $15.99 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.58 | 2025 | Rexulti |
| Pfizer INC. | $13.45 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $13.26 | 2024 | |
| Therapeuticsmd, INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.